Forbes July 19, 2024
Dr. Tejaswi Kompala

As an endocrinologist who has cared for patients with diabetes and obesity for over a decade, it’s incredibly encouraging to see the increasing attention and investment in the field of diabetes management.

Our field is energized by the progress we’ve seen over the past several years. And as I reflect on my conversations with health leaders, researchers and scientists at the American Diabetes Association (ADA) Scientific Sessions recently, I think change in our industry is only accelerating.

The rising demand for GLP-1s, advancements in research and technology and the increasing focus on health disparities are shaping the future of diabetes management in profound ways, and uncovering challenges for employers and health plans. As these developments continue to shape the future...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Employer, Patient / Consumer, Provider
Why CEOs Keep Betting On The Wrong Innovations?
The High Price of Treatment Resistant Depression for Employers
The Pandemic Proved That Remote Leadership Works
More than 65 Organizations Call on Workplaces to Provide Comprehensive Obesity Care Coverage
The state of AI: How organizations are rewiring to capture value

Share This Article